Latest Content

Melody Tavakoli, OD, stated that patient complicance remains one of the biggest challenges for contact lens wearers.

Clinical trial data support the Deseyne contact lens, the first FDA-designated EDOF soft contact lens, as a new daily disposable option for presbyopia.

Lori-Ann Christie, PhD, detailed a poster presentation titled "Comparative Analysis of AREDS2 and AREDS2+B Vitamin Complex in an in vitro Model of Age-Related Macular Degeneration."

Will eye drops be an option in the future for keratoconic patients? Clark Chang, OD, MSA, MSc, FAAO, gave us the run-down of what active research may make possible.

Preservative-free bimatoprost gel now offers once-daily glaucoma and ocular hypertension IOP reduction, aiming to boost comfort, tolerability, and long-term adherence.

Mile Brujic, OD, FAAO, stated in a poster presentation that a multi-practice study found that the lens had particularly positive effects on patients who reported dryness symptoms.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, details the challenges of managing dry eye in contact lens wearers via accurate diagnosis and thoughtful lens fitting.

Mitch Ibach, OD, FAAO, said that medication optimization is key when taking the interventional approach to glaucoma.

The emerging technology offers a new paradigm for treating a group of eye diseases.

Mohammad Rafieetary, OD, FAAO, FORS, DipABO, ABCMO, discussed his AOA 2026 presentation "Eye of the Needle Returns: Navigating the Patient’s Journey Receiving Intravitreal Injections."

A cross-sectional study of nearly 10,000 nursing home residents found a clear dose-response relationship between vision loss and cognitive impairment, with blind residents having nearly 3 times the odds of cognitive loss compared with those with normal vision.

A Johnson & Johnson Vision poster found a novel multifocal toric daily disposable contact lens delivered visual acuity within 1 letter and comparable fitting success to an existing nontoric multifocal lens, extending coverage to presbyopes with up to 1.75D astigmatism.

Melody Tavakoli, OD, said that she has found that workhorse in Johnson & Johnson's Oasys lens family.